# Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

> **NCT00281320** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 122 (actual)

## Conditions studied

- Psychosis

## Interventions

- **DRUG:** Asenapine

## Key facts

- **NCT ID:** NCT00281320
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00281320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00281320, "Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00281320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*